FFIV insider files Rule 144 for 1,300 shares; July–Sep 2025 sales disclosed

Rhea-AI Filing Summary

Form 144 notice indicates proposed sale of 1,300 common shares by an officer/person for whose account the securities are to be sold, to be executed through Morgan Stanley Smith Barney LLC on 09/02/2025 with an aggregate market value of $402,493.00. The filing shows the 1,300 shares were acquired as restricted stock on 02/01/2021 (589 shares) and 11/01/2022 (711 shares). The issuer’s outstanding shares are listed as 57,447,170. The filing also discloses two prior common-stock sales by the same person: 1,300 shares on 08/01/2025 for $400,582.00 and 1,300 shares on 07/01/2025 for $382,616.00. The signer represents they are not aware of undisclosed material adverse information and includes the standard criminal-misstatement warning.

Positive

• Complete disclosure of broker, share counts, acquisition dates, and aggregate market value
• Shows provenance of shares as restricted stock grants (2021 and 2022), clarifying the nature of holdings
• Includes prior sales for transparent transaction history

Negative

• Insider sales reported in July, August, and a proposed sale in September 2025, indicating ongoing dispositions
• Aggregate value disclosed ($402,493) represents a sale of shares rather than an acquisition

Insights

Securities Compliance Analyst

TL;DR: Routine Rule 144 disclosure of insider share sales and planned sale; provides transparency but does not itself state material company changes.

The filing documents a proposed sale under Rule 144 of 1,300 common shares through Morgan Stanley Smith Barney LLC and records prior sales in July and August 2025. Acquisition details show the shares originated from restricted stock awards in 2021 and 2022, consistent with typical post-vesting dispositions. The filer makes the required representation about absence of undisclosed material adverse information. From a compliance perspective the form appears to include required elements: broker, number of shares, aggregate value, acquisition dates and nature, and recent sales history.

Equity Transactions Specialist

TL;DR: Multiple near-term insider sales disclosed; the form provides clear trade cadence and provenance of shares.

The notice identifies Morgan Stanley as the executing broker and ties the sold shares to specific restricted stock grant dates and quantities (589 and 711). The presence of two prior monthly sales (July and August 2025) plus this proposed September sale shows a sequence of dispositions, and the filing quantifies proceeds for prior trades. The document is focused on disclosure of planned and past transactions rather than corporate operational matters; it enables investors and compliance teams to track insider selling activity.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1300	402493.00	57447170	09/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/01/2022	Restricted Stock	ISSUER			711	11/01/2022	Not Applicable
Common	02/01/2021	Restricted Stock	ISSUER			589	02/01/2021	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
FRANCOIS LOCOH-DONOU 801 5TH AVENUE Seattle WA 98104	Common	08/01/2025	1300	400582.00
FRANCOIS LOCOH-DONOU 801 5TH AVENUE Seattle WA 98104	Common	07/01/2025	1300	382616.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for FFIV report?

The Form 144 reports a proposed Rule 144 sale of 1,300 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $402,493.00 to be sold on 09/02/2025.

Who is the named seller and where are prior sales recorded?

The seller is listed as Francois Locoh-Donou with prior reported sales of 1,300 shares on 08/01/2025 (proceeds $400,582.00) and 07/01/2025 (proceeds $382,616.00).

How were the shares acquired?

The 1,300 shares were acquired as restricted stock: 589 shares on 02/01/2021 and 711 shares on 11/01/2022.

What exchange and outstanding share count are listed?

The sale is to be executed on NASDAQ and the filing lists 57,447,170 shares outstanding for the issuer.

Does the filing state any undisclosed material information?

By signing the notice the person represents they do not know of any material adverse information that has not been publicly disclosed.